Hangzhou Deep Informatics closes Series B round, hauls in over RMB100m

Hangzhou Deep Informatics has garnered over 100 million yuan in a Series B financing round, led by China International Capital Corporation, with participation from existing investors Legend Capital and Jiangmen Venture Capital.

Hangzhou Deep Informatics has garnered over 100 million yuan in a Series B financing round, led by China International Capital Corporation, with participation from existing investors Legend Capital and Jiangmen Venture Capital.

Proceeds from this round will mainly be used to boost research and development, accelerate artificial intelligence and digitalization processes, and expand pathological businesses.

Founded in 2017 in Hangzhou, Deep Informatics has always focused on pathological services in China. With the dedicated aim of providing comprehensive solutions for Chinese pathologists, it has developed many AI-based auxiliary diagnostic tools and relevant businesses, including cloud storage, big data management, remote meeting, etc.

Integrating clinical practice needs, Deep Informatics’ independently-developed software and hardware products such as intelligent microscopes, scanners of various styles, pathological diagnosis image processing software, pathology information system and remote consultation system have been approved for commercialization in 2019 and obtained approval by more than 300 Chinese triple-A hospitals and professional third-party testing companies in China.

In the meantime, Deep Informatics is actively exploring the application for the registration certificate of third-class pathological AI diagnostic medical devices.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/02/hangzhou-deep-informatics-closes-series-b-round-hauls-in-over-rmb100m/.

Leave a Reply

Your email address will not be published. Required fields are marked *